FIELD: medicine.
SUBSTANCE: invention relates to a composition for treating addiction and / or pain. Disclosed are noribogaine compositions with said purpose, wherein at least 95 % of noribogaine is present as 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and further wherein said composition comprises not more than 0.5 wt% ibogaine relative to total amount of noribogaine.
EFFECT: technical result consists in obtaining noribogaine substantially free of ibogaine that displays hallucinogenic properties.
15 cl
Title |
Year |
Author |
Number |
METHODS AND COMPOSITIONS FOR PRODUCING NORIBOGAINE FROM VOACANGINE |
2012 |
- Mesh Debora K.
- Moriarti Robert M.
- Gless Richard D.
|
RU2592698C2 |
METHOD OF SYNTHESIS OF PEPTIDES, PEPTIDES, IMMUNOMODULATING COMPOSITION AND A METHOD OF REGULATION OF INSUFFICIENT OR EXCESSIVE FUNCTION OF T-CELLS IN PATIENT |
1989 |
- Dzhordzh Khivner[Us]
- Gidson Goldshtejn[Us]
- Tapan Audkhia[In]
|
RU2060998C1 |
NEW CIS-IMIDAZOLINES |
2005 |
- Khejli Gregori Dzhej
- Kong Norman
- Lju Ehmili Ajtsun'
- Vu Binkh Tkhankh
|
RU2408593C2 |
2-(2-AMINO-1,6-DIHYDRO-6-OXOPURIN-9-YL)METOXY-3-HYDROXY- 1-PROPANYL-L-VALINATE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION AND HYDROXY AND/OR AMINO PROTECTED 2-(2- AMINO-1,6-DIHYDRO-6-OXOPYRIN-9-YL) METHOXY-3-HYDROXY-1- PROPANYL-L-VALINATE |
1995 |
- Dzhon Dzh.Nestor
- Skott V.Vombl
- Khans Maag
|
RU2133749C1 |
PIPERIDINYL-SUBSTITUTED METHANOANTHRACENES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A PHARMACEUTICAL COMPOSITION BASED ON SAID AND METHODS OF THEIR SYNTHESIS |
1994 |
- Majkl Taddeus Klimas
- Mark Ornal Terpko
|
RU2128178C1 |
SPIROAZACYCLIC COMPOUNDS, METHOD FOR INHIBITION IF ACTIVITY OR ACTIVATION OF SEROTONIN 5-НТ2А RECEPTOR, METHOD FOR TREATMENT OF MORBID STATE ASSOCIATED WITH SEROTONIN 5-НТ2А RECEPTOR AND THEIR USING |
2002 |
|
RU2315051C2 |
RING SUBSTITUTED 2-AMINO-1,2,3,4-TETRAHYDRO NAPHTHALENES OR 3-AMINOCHROMATES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID ADDITIVE SALTS AND METHOD FOR THEIR PRODUCTION |
1992 |
- Krejg Stiven Khekhstetter[Us]
- Dajan Linn Kh'Juser[Us]
- Dzhon Menert Skaus[Us]
- Robert Daniehl' Tajtus[Us]
|
RU2057751C1 |
COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND PROPHYLAXIS OF ENDOMETRITIS, INTERMEDIATE COMPOUND |
1996 |
- Kimberli O.Kameron
- Pol' A.Dasilva Zhardine
- Robert L.Rozati
|
RU2130454C1 |
DIPEPTIDES CONTAINING 2-THIOACYL GROUP AT N-TERMINAL AMINO ACID RESIDUE AS VASOPEPTIDASE INHIBITORS |
2002 |
|
RU2298559C2 |
TETRAHYDROQUINOLIN DERIVATIVES, BASED ON THEM PHARMACEUTICAL COMPOSITION AND THEIR APPLICATION AS FERTILITY REGULATOR |
2003 |
- Timmers Kornelis Marius
- Karstens Villem Frederik Jokhan
|
RU2328487C2 |